Global Josamycin Tablets Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Josamycin Tablets Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Josamycin Tablets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 200mg
  • 1.2.3 50mg
• 1.3 Market by Application
  • 1.3.1 Global Josamycin Tablets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Josamycin Tablets Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Josamycin Tablets Revenue by Region
  • 2.2.1 Global Josamycin Tablets Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Josamycin Tablets Revenue by Region (2019-2024)
  • 2.2.3 Global Josamycin Tablets Revenue by Region (2025-2030)
  • 2.2.4 Global Josamycin Tablets Revenue Market Share by Region (2019-2030)
• 2.3 Global Josamycin Tablets Sales Estimates and Forecasts 2019-2030
• 2.4 Global Josamycin Tablets Sales by Region
  • 2.4.1 Global Josamycin Tablets Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Josamycin Tablets Sales by Region (2019-2024)
  • 2.4.3 Global Josamycin Tablets Sales by Region (2025-2030)
  • 2.4.4 Global Josamycin Tablets Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Josamycin Tablets Sales by Manufacturers
  • 3.1.1 Global Josamycin Tablets Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Josamycin Tablets Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Josamycin Tablets in 2023
• 3.2 Global Josamycin Tablets Revenue by Manufacturers
  • 3.2.1 Global Josamycin Tablets Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Josamycin Tablets Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Josamycin Tablets Revenue in 2023
• 3.3 Global Key Players of Josamycin Tablets, Industry Ranking, 2021 VS 2022
• 3.4 Global Josamycin Tablets Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Josamycin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Josamycin Tablets, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Josamycin Tablets, Product Offered and Application
• 3.8 Global Key Manufacturers of Josamycin Tablets, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Josamycin Tablets Sales by Type
  • 4.1.1 Global Josamycin Tablets Historical Sales by Type (2019-2024)
  • 4.1.2 Global Josamycin Tablets Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Josamycin Tablets Sales Market Share by Type (2019-2030)
• 4.2 Global Josamycin Tablets Revenue by Type
  • 4.2.1 Global Josamycin Tablets Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Josamycin Tablets Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Josamycin Tablets Revenue Market Share by Type (2019-2030)
• 4.3 Global Josamycin Tablets Price by Type
  • 4.3.1 Global Josamycin Tablets Price by Type (2019-2024)
  • 4.3.2 Global Josamycin Tablets Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Josamycin Tablets Sales by Application
  • 5.1.1 Global Josamycin Tablets Historical Sales by Application (2019-2024)
  • 5.1.2 Global Josamycin Tablets Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Josamycin Tablets Sales Market Share by Application (2019-2030)
• 5.2 Global Josamycin Tablets Revenue by Application
  • 5.2.1 Global Josamycin Tablets Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Josamycin Tablets Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Josamycin Tablets Revenue Market Share by Application (2019-2030)
• 5.3 Global Josamycin Tablets Price by Application
  • 5.3.1 Global Josamycin Tablets Price by Application (2019-2024)
  • 5.3.2 Global Josamycin Tablets Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Josamycin Tablets Market Size by Type
  • 6.1.1 US & Canada Josamycin Tablets Sales by Type (2019-2030)
  • 6.1.2 US & Canada Josamycin Tablets Revenue by Type (2019-2030)
• 6.2 US & Canada Josamycin Tablets Market Size by Application
  • 6.2.1 US & Canada Josamycin Tablets Sales by Application (2019-2030)
  • 6.2.2 US & Canada Josamycin Tablets Revenue by Application (2019-2030)
• 6.3 US & Canada Josamycin Tablets Market Size by Country
  • 6.3.1 US & Canada Josamycin Tablets Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Josamycin Tablets Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Josamycin Tablets Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Josamycin Tablets Market Size by Type
  • 7.1.1 Europe Josamycin Tablets Sales by Type (2019-2030)
  • 7.1.2 Europe Josamycin Tablets Revenue by Type (2019-2030)
• 7.2 Europe Josamycin Tablets Market Size by Application
  • 7.2.1 Europe Josamycin Tablets Sales by Application (2019-2030)
  • 7.2.2 Europe Josamycin Tablets Revenue by Application (2019-2030)
• 7.3 Europe Josamycin Tablets Market Size by Country
  • 7.3.1 Europe Josamycin Tablets Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Josamycin Tablets Revenue by Country (2019-2030)
  • 7.3.3 Europe Josamycin Tablets Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Josamycin Tablets Market Size by Type
  • 8.1.1 China Josamycin Tablets Sales by Type (2019-2030)
  • 8.1.2 China Josamycin Tablets Revenue by Type (2019-2030)
• 8.2 China Josamycin Tablets Market Size by Application
  • 8.2.1 China Josamycin Tablets Sales by Application (2019-2030)
  • 8.2.2 China Josamycin Tablets Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Josamycin Tablets Market Size by Type
  • 9.1.1 Asia Josamycin Tablets Sales by Type (2019-2030)
  • 9.1.2 Asia Josamycin Tablets Revenue by Type (2019-2030)
• 9.2 Asia Josamycin Tablets Market Size by Application
  • 9.2.1 Asia Josamycin Tablets Sales by Application (2019-2030)
  • 9.2.2 Asia Josamycin Tablets Revenue by Application (2019-2030)
• 9.3 Asia Josamycin Tablets Market Size by Region
  • 9.3.1 Asia Josamycin Tablets Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Josamycin Tablets Revenue by Region (2019-2030)
  • 9.3.3 Asia Josamycin Tablets Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Josamycin Tablets Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Josamycin Tablets Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Josamycin Tablets Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Josamycin Tablets Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Josamycin Tablets Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Josamycin Tablets Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Josamycin Tablets Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Josamycin Tablets Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Josamycin Tablets Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Josamycin Tablets Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Astellas Pharma
  • 11.1.1 Astellas Pharma Company Information
  • 11.1.2 Astellas Pharma Overview
  • 11.1.3 Astellas Pharma Josamycin Tablets Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Astellas Pharma Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Astellas Pharma Recent Developments
• 11.2 Shanghai Sine Pharmaceutical
  • 11.2.1 Shanghai Sine Pharmaceutical Company Information
  • 11.2.2 Shanghai Sine Pharmaceutical Overview
  • 11.2.3 Shanghai Sine Pharmaceutical Josamycin Tablets Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Shanghai Sine Pharmaceutical Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Shanghai Sine Pharmaceutical Recent Developments
• 11.3 Guangzhou Baiyunshan Guanghua Pharmaceutical
  • 11.3.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  • 11.3.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Overview
  • 11.3.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
• 11.4 CSPC OUYI PHARMACEUTICAL
  • 11.4.1 CSPC OUYI PHARMACEUTICAL Company Information
  • 11.4.2 CSPC OUYI PHARMACEUTICAL Overview
  • 11.4.3 CSPC OUYI PHARMACEUTICAL Josamycin Tablets Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 CSPC OUYI PHARMACEUTICAL Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 CSPC OUYI PHARMACEUTICAL Recent Developments
• 11.5 Harbin Pharmaceutical Group
  • 11.5.1 Harbin Pharmaceutical Group Company Information
  • 11.5.2 Harbin Pharmaceutical Group Overview
  • 11.5.3 Harbin Pharmaceutical Group Josamycin Tablets Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Harbin Pharmaceutical Group Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Harbin Pharmaceutical Group Recent Developments
• 11.6 Guilin Nantang Pharmaceutical
  • 11.6.1 Guilin Nantang Pharmaceutical Company Information
  • 11.6.2 Guilin Nantang Pharmaceutical Overview
  • 11.6.3 Guilin Nantang Pharmaceutical Josamycin Tablets Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Guilin Nantang Pharmaceutical Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Guilin Nantang Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Josamycin Tablets Industry Chain Analysis
• 12.2 Josamycin Tablets Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Josamycin Tablets Production Mode & Process
• 12.4 Josamycin Tablets Sales and Marketing
  • 12.4.1 Josamycin Tablets Sales Channels
  • 12.4.2 Josamycin Tablets Distributors
• 12.5 Josamycin Tablets Customers

13 Josamycin Tablets Market Dynamics

• 13.1 Josamycin Tablets Industry Trends
• 13.2 Josamycin Tablets Market Drivers
• 13.3 Josamycin Tablets Market Challenges
• 13.4 Josamycin Tablets Market Restraints

14 Key Findings in the Global Josamycin Tablets Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Josamycin Tablets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 200mg

Table 3. Major Manufacturers of 50mg

Table 4. Global Josamycin Tablets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Josamycin Tablets Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Josamycin Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Josamycin Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Josamycin Tablets Revenue Market Share by Region (2019-2024)

Table 9. Global Josamycin Tablets Revenue Market Share by Region (2025-2030)

Table 10. Global Josamycin Tablets Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Josamycin Tablets Sales by Region (2019-2024) & (K Units)

Table 12. Global Josamycin Tablets Sales by Region (2025-2030) & (K Units)

Table 13. Global Josamycin Tablets Sales Market Share by Region (2019-2024)

Table 14. Global Josamycin Tablets Sales Market Share by Region (2025-2030)

Table 15. Global Josamycin Tablets Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Josamycin Tablets Sales Share by Manufacturers (2019-2024)

Table 17. Global Josamycin Tablets Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Josamycin Tablets Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Josamycin Tablets, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Josamycin Tablets Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Josamycin Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Josamycin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Josamycin Tablets as of 2023)

Table 23. Global Key Manufacturers of Josamycin Tablets, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Josamycin Tablets, Product Offered and Application

Table 25. Global Key Manufacturers of Josamycin Tablets, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Josamycin Tablets Sales by Type (2019-2024) & (K Units)

Table 28. Global Josamycin Tablets Sales by Type (2025-2030) & (K Units)

Table 29. Global Josamycin Tablets Sales Share by Type (2019-2024)

Table 30. Global Josamycin Tablets Sales Share by Type (2025-2030)

Table 31. Global Josamycin Tablets Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Josamycin Tablets Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Josamycin Tablets Revenue Share by Type (2019-2024)

Table 34. Global Josamycin Tablets Revenue Share by Type (2025-2030)

Table 35. Josamycin Tablets Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Josamycin Tablets Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Josamycin Tablets Sales by Application (2019-2024) & (K Units)

Table 38. Global Josamycin Tablets Sales by Application (2025-2030) & (K Units)

Table 39. Global Josamycin Tablets Sales Share by Application (2019-2024)

Table 40. Global Josamycin Tablets Sales Share by Application (2025-2030)

Table 41. Global Josamycin Tablets Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Josamycin Tablets Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Josamycin Tablets Revenue Share by Application (2019-2024)

Table 44. Global Josamycin Tablets Revenue Share by Application (2025-2030)

Table 45. Josamycin Tablets Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Josamycin Tablets Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Josamycin Tablets Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Josamycin Tablets Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Josamycin Tablets Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Josamycin Tablets Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Josamycin Tablets Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Josamycin Tablets Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Josamycin Tablets Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Josamycin Tablets Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Josamycin Tablets Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Josamycin Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Josamycin Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Josamycin Tablets Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Josamycin Tablets Sales by Country (2025-2030) & (K Units)

Table 60. Europe Josamycin Tablets Sales by Type (2019-2024) & (K Units)

Table 61. Europe Josamycin Tablets Sales by Type (2025-2030) & (K Units)

Table 62. Europe Josamycin Tablets Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Josamycin Tablets Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Josamycin Tablets Sales by Application (2019-2024) & (K Units)

Table 65. Europe Josamycin Tablets Sales by Application (2025-2030) & (K Units)

Table 66. Europe Josamycin Tablets Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Josamycin Tablets Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Josamycin Tablets Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Josamycin Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Josamycin Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Josamycin Tablets Sales by Country (2019-2024) & (K Units)

Table 72. Europe Josamycin Tablets Sales by Country (2025-2030) & (K Units)

Table 73. China Josamycin Tablets Sales by Type (2019-2024) & (K Units)

Table 74. China Josamycin Tablets Sales by Type (2025-2030) & (K Units)

Table 75. China Josamycin Tablets Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Josamycin Tablets Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Josamycin Tablets Sales by Application (2019-2024) & (K Units)

Table 78. China Josamycin Tablets Sales by Application (2025-2030) & (K Units)

Table 79. China Josamycin Tablets Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Josamycin Tablets Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Josamycin Tablets Sales by Type (2019-2024) & (K Units)

Table 82. Asia Josamycin Tablets Sales by Type (2025-2030) & (K Units)

Table 83. Asia Josamycin Tablets Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Josamycin Tablets Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Josamycin Tablets Sales by Application (2019-2024) & (K Units)

Table 86. Asia Josamycin Tablets Sales by Application (2025-2030) & (K Units)

Table 87. Asia Josamycin Tablets Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Josamycin Tablets Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Josamycin Tablets Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Josamycin Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Josamycin Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Josamycin Tablets Sales by Region (2019-2024) & (K Units)

Table 93. Asia Josamycin Tablets Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Josamycin Tablets Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Josamycin Tablets Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Josamycin Tablets Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Josamycin Tablets Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Josamycin Tablets Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Josamycin Tablets Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Josamycin Tablets Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Josamycin Tablets Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Josamycin Tablets Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Josamycin Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Josamycin Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Josamycin Tablets Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Josamycin Tablets Sales by Country (2025-2030) & (K Units)

Table 107. Astellas Pharma Company Information

Table 108. Astellas Pharma Description and Major Businesses

Table 109. Astellas Pharma Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Astellas Pharma Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Astellas Pharma Recent Developments

Table 112. Shanghai Sine Pharmaceutical Company Information

Table 113. Shanghai Sine Pharmaceutical Description and Major Businesses

Table 114. Shanghai Sine Pharmaceutical Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Shanghai Sine Pharmaceutical Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Shanghai Sine Pharmaceutical Recent Developments

Table 117. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information

Table 118. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Major Businesses

Table 119. Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments

Table 122. CSPC OUYI PHARMACEUTICAL Company Information

Table 123. CSPC OUYI PHARMACEUTICAL Description and Major Businesses

Table 124. CSPC OUYI PHARMACEUTICAL Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. CSPC OUYI PHARMACEUTICAL Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. CSPC OUYI PHARMACEUTICAL Recent Developments

Table 127. Harbin Pharmaceutical Group Company Information

Table 128. Harbin Pharmaceutical Group Description and Major Businesses

Table 129. Harbin Pharmaceutical Group Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Harbin Pharmaceutical Group Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Harbin Pharmaceutical Group Recent Developments

Table 132. Guilin Nantang Pharmaceutical Company Information

Table 133. Guilin Nantang Pharmaceutical Description and Major Businesses

Table 134. Guilin Nantang Pharmaceutical Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Guilin Nantang Pharmaceutical Josamycin Tablets Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Guilin Nantang Pharmaceutical Recent Developments

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Josamycin Tablets Distributors List

Table 140. Josamycin Tablets Customers List

Table 141. Josamycin Tablets Market Trends

Table 142. Josamycin Tablets Market Drivers

Table 143. Josamycin Tablets Market Challenges

Table 144. Josamycin Tablets Market Restraints

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Josamycin Tablets Product Picture

Figure 2. Global Josamycin Tablets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Josamycin Tablets Market Share by Type: 2023 & 2030

Figure 4. 200mg Product Picture

Figure 5. 50mg Product Picture

Figure 6. Global Josamycin Tablets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Josamycin Tablets Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Josamycin Tablets Report Years Considered

Figure 12. Global Josamycin Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 14. Global Josamycin Tablets Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 15. Global Josamycin Tablets Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Josamycin Tablets Revenue Market Share by Region (2019-2030)

Figure 17. Global Josamycin Tablets Sales (2019-2030) & (K Units)

Figure 18. Global Josamycin Tablets Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 19. Global Josamycin Tablets Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Josamycin Tablets Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Josamycin Tablets Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Josamycin Tablets Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Josamycin Tablets Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Josamycin Tablets Sales YoY (2019-2030) & (K Units)

Figure 25. China Josamycin Tablets Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Josamycin Tablets Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Josamycin Tablets Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Josamycin Tablets Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Josamycin Tablets Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Global Josamycin Tablets Sales Share by Manufacturers (2023)

Figure 31. The Josamycin Tablets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. Global Josamycin Tablets Revenue Share by Manufacturers (2023)

Figure 33. The Top 5 and 10 Largest Manufacturers of Josamycin Tablets in the World: Market Share by Josamycin Tablets Revenue in 2023

Figure 34. Global Josamycin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Josamycin Tablets Sales Market Share by Type (2019-2030)

Figure 36. Global Josamycin Tablets Revenue Market Share by Type (2019-2030)

Figure 37. Global Josamycin Tablets Sales Market Share by Application (2019-2030)

Figure 38. Global Josamycin Tablets Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Josamycin Tablets Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Josamycin Tablets Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Josamycin Tablets Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Josamycin Tablets Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Josamycin Tablets Revenue Share by Country (2019-2030)

Figure 44. US & Canada Josamycin Tablets Sales Share by Country (2019-2030)

Figure 45. US Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Josamycin Tablets Sales Market Share by Type (2019-2030)

Figure 48. Europe Josamycin Tablets Revenue Market Share by Type (2019-2030)

Figure 49. Europe Josamycin Tablets Sales Market Share by Application (2019-2030)

Figure 50. Europe Josamycin Tablets Revenue Market Share by Application (2019-2030)

Figure 51. Europe Josamycin Tablets Revenue Share by Country (2019-2030)

Figure 52. Europe Josamycin Tablets Sales Share by Country (2019-2030)

Figure 53. Germany Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 54. France Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 58. China Josamycin Tablets Sales Market Share by Type (2019-2030)

Figure 59. China Josamycin Tablets Revenue Market Share by Type (2019-2030)

Figure 60. China Josamycin Tablets Sales Market Share by Application (2019-2030)

Figure 61. China Josamycin Tablets Revenue Market Share by Application (2019-2030)

Figure 62. Asia Josamycin Tablets Sales Market Share by Type (2019-2030)

Figure 63. Asia Josamycin Tablets Revenue Market Share by Type (2019-2030)

Figure 64. Asia Josamycin Tablets Sales Market Share by Application (2019-2030)

Figure 65. Asia Josamycin Tablets Revenue Market Share by Application (2019-2030)

Figure 66. Asia Josamycin Tablets Revenue Share by Region (2019-2030)

Figure 67. Asia Josamycin Tablets Sales Share by Region (2019-2030)

Figure 68. Japan Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 72. India Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 73. Australia Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Josamycin Tablets Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Josamycin Tablets Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Josamycin Tablets Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Josamycin Tablets Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Josamycin Tablets Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Josamycin Tablets Sales Share by Country (2019-2030)

Figure 80. Brazil Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Josamycin Tablets Revenue (2019-2030) & (US$ Million)

Figure 85. Josamycin Tablets Value Chain

Figure 86. Josamycin Tablets Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed